Delivery Order SPE2DB20D3303-SPE2DB25FA1ED
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $2,517.06. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be completed by November 19, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Januvia 50 mg tablets (90-count packages) with a contract value of $1,056.72. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Januvia 100 mg tablets (90-count packages) with a ceiling value of $1,056.72. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order is set to be completed by November 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,637.19. This non-set-aside award represents a competitive procurement for pharmaceutical products supporting federal medical supply requirements. The order is scheduled for ultimate completion by June 30, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $1,761.10. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 50 mg tablets (90-count) valued at $1,316.00. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was awarded on a competitive, non-set-aside basis. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $5,106.30 under a firm fixed price arrangement. This non-set-aside delivery order is due for completion by October 23, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a competitive procurement action that leverages AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,891.24 on August 6, 2025, for the supply of Januvia 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1EDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Januvia 50 mg tablets (90-count packaging) under a firm fixed-price contract with a ceiling value of $1,455.28. This non-set-aside delivery order is scheduled for completion by July 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction within the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime vehicle supports comprehensive global pharmaceutical supply operations for military healthcare programs and related federal medical systems. AmerisourceBergen, a major pharmaceutical distributor, maintains an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical supplies, positioning it as a key vendor for Defense Health Agency procurement needs and broader military healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/9/25 |